 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, November 1, 2001, 21(21):8648-8654
Cutaneous Vasoconstriction Contributes to Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) in Conscious Rabbits
N. P. Pedersen and W. W. Blessing Departments of Medicine and Physiology, Centre for Neuroscience, Flinders University, Bedford Park 5042, South Australia, Australia
3,4-Methylenedioxymethamphetamine (MDMA; "Ecstasy") increases body temperature. This process could be associated with increased cutaneous blood flow, as normally occurs with exercise-induced hyperthermia. Alternatively, an MDMA-induced fall in cutaneous blood flow could contribute to the hyperthermia by diminishing normal heat transfer from the body to the environment. We investigated these possibilities by administering MDMA (1.5-6 mg/kg, i.v.) to conscious freely moving rabbits, determining effects on body temperature, cutaneous blood flow (measured by a Doppler ultrasonic probe that was chronically implanted around the ear pinna artery), and other cardiovascular parameters. MDMA caused a dose-dependent increase in body temperature (from 38.3 ± 0.3 to 41.2 ± 0.4°C after 6 mg/kg; p < 0.01; n = 5), preceded and accompanied by a dose-dependent cutaneous vasoconstriction (from 29 ± 6 to 5 ± 1 cm/sec after 6 mg/kg; p < 0.01; n = 5). MDMA (3 mg/kg) did not change blood flow to the mesenteric vascular bed. Prior unilateral cervical sympathectomy reduced the increase in body temperature elicited by MDMA (6 mg/kg) from 2.0 ± 0.2 to 1.3 ± 0.2°C (p < 0.01; n = 5). On the denervated side, ear pinna blood flow after MDMA injection was 13 ± 3 cm/sec, compared with 3 ± 1 cm/sec on the sympathetically intact side (p < 0.05; n = 5). Thus, sympathetically mediated cutaneous vasoconstriction is one mechanism whereby MDMA causes hyperthermia. Reversal of cutaneous vasoconstriction by appropriate pharmacological means could be of therapeutic benefit in humans suffering from life-threatening hyperthermia induced by MDMA.
Key words: MDMA; ecstasy; temperature regulation; skin blood flow; heat loss; serotonin; 5-HT; hyperthermia
Copyright © 2001 Society for Neuroscience 0270-6474/01/21218648-07$05.00/0
This article has been cited by other articles:
D. E. Rusyniak, M. V. Zaretskaia, D. V. Zaretsky, and J. A. DiMicco
3,4-Methylenedioxymethamphetamine- and 8-Hydroxy-2-di-n-propylamino-tetralin-Induced Hypothermia: Role and Location of 5-Hydroxytryptamine 1A Receptors
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 477 - 487.
[Abstract] [Full Text] [PDF]
M. L. Banks, J. E. Sprague, D. F. Kisor, P. W. Czoty, D. E. Nichols, and M. A. Nader
Ambient Temperature Effects on 3,4-Methylenedioxymethamphetamine-Induced Thermodysregulation and Pharmacokinetics in Male Monkeys
Drug Metab. Dispos., October 1, 2007; 35(10): 1840 - 1845.
[Abstract] [Full Text] [PDF]
N. Easton and C. A. Marsden
Ecstasy: Are animal data consistent between species and can they translate to humans?
J Psychopharmacol, March 1, 2006; 20(2): 194 - 210.
[Abstract] [PDF]
D. E. Rusyniak, S. L. Tandy, S. K. Hekmatyar, E. Mills, D. J. Smith, N. Bansal, D. MacLellan, M.-E. Harper, and J. E. Sprague
The Role of Mitochondrial Uncoupling in 3,4-Methylenedioxymethamphetamine-Mediated Skeletal Muscle Hyperthermia and Rhabdomyolysis
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 629 - 639.
[Abstract] [Full Text] [PDF]
W. W. Blessing, B. Seaman, N. P. Pedersen, and Y. Ootsuka
Clozapine Reverses Hyperthermia and Sympathetically Mediated Cutaneous Vasoconstriction Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) in Rabbits and Rats
J. Neurosci., July 16, 2003; 23(15): 6385 - 6391.
[Abstract] [Full Text] [PDF]
J. E. Sprague, M. L. Banks, V. J. Cook, and E. M. Mills
Hypothalamic-Pituitary-Thyroid Axis and Sympathetic Nervous System Involvement in Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy)
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 159 - 166.
[Abstract] [Full Text]
|
|
|
|
 |
|